Publications by authors named "Jieheng Lin"

Claim this Profile
A
A Rare Histologic Transformation from EGFR-Positive Lung Adenocarcinoma to EGFR-Negative Squamous Cell Carcinoma After EGFR-TKIs Resistance: A Case Report.
Mengli Qiu, Peiwen Guo, Jieheng Lin, Sisi Wang, Wenping Wang

Onco Targets Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Durable response of immuno-chemotherapy targeting a rare ROS1 fusion-positive extensive-stage SCLC patient after primary resistance to crizotinib.
Mengli Qiu, Peiwen Guo, Sisi Wang, Yong Zhu, Siqi Wu, Jieheng Lin

Front Pharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung adenocarcinoma with an uncommon CCDC85A-ALK fusion responding to alectinib: A case report.
Jieheng Lin, Wenping Wang, Jietao Lin, Ruilian Chen, Yang Cao

J Cell Mol Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Complete Remission of An Advanced Gastric Adenocarcinoma After Camrelizumab Plus Chemotherapy Followed by Camrelizumab Plus Capecitabine: A Case Report.
Jieheng Lin, Jianying Yang, Wenping Wang, Xiaotong Lin, Yang Cao

Front Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biliary hydrothorax after percutaneous transhepatic biliary drainage: A rare complication.
Jieheng Lin, Jietao Lin, Jianning Liang, Yang Cao

Asian J Surg· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosis.
Guifang Yu, Jieheng Lin, Chengcheng Liu, Kailian Hou, Min Liang

Sci Rep· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis